Page last updated: 2024-11-05

ticlopidine and Dyskinesia Syndromes

ticlopidine has been researched along with Dyskinesia Syndromes in 2 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Komarov, AL1
Kropacheva, ES1
Tarasova, TN1
Dobrovol'skiĭ, AB1
Titaeva, EV1
Mironova, IY1
Naumov, VG1
Panchenko, EP1
Zatevakhin, II1
Zolkin, VN1
Shiller, EE1

Trials

2 trials available for ticlopidine and Dyskinesia Syndromes

ArticleYear
[Effect of therapy with clopidogrel on walking tolerance and parameters of hemostasis in patients with atherosclerosis of lower extremities and intermittent claudication].
    Kardiologiia, 2002, Volume: 42, Issue:3

    Topics: Aged; Arteriosclerosis; Clopidogrel; Female; Hemostasis; Humans; Lower Extremity; Male; Middle Aged;

2002
[The assessment of TIKLO efficacy in patients with intermittent claudication].
    Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery, 2007, Volume: 13, Issue:2

    Topics: Aged; Atherosclerosis; Exercise Test; Female; Humans; Intermittent Claudication; Lower Extremity; Ma

2007